Combined HAT/EZH2 modulation leads to cancer-selective cell death - Institut Carnot CALYM Access content directly
Journal Articles Oncotarget Year : 2018

Combined HAT/EZH2 modulation leads to cancer-selective cell death

Paul Flicek
  • Function : Author
  • PersonId : 919968


Epigenetic alterations have been associated with both pathogenesis and progression of cancer. By screening of library compounds, we identified a novel hybrid epi-drug MC2884, a HAT/EZH2 inhibitor, able to induce bona fide cancer-selective cell death in both solid and hematological cancers in vitro, ex vivo and in vivo xenograft models. Anticancer action was due to an epigenome modulation by H3K27me3, H3K27ac, H3K9/14ac decrease, and to caspase-dependent apoptosis induction. MC2884 triggered mitochondrial pathway apoptosis by up-regulation of cleaved-BID, and strong down-regulation of BCL2. Even aggressive models of cancer, such as p53-/- or TET2-/- cells, responded to MC2884, suggesting MC2884 therapeutic potential also for the therapy of TP53 or TET2-deficient human cancers. MC2884 induced massive apoptosis in ex vivo human primary leukemia blasts with poor prognosis in vivo, by targeting BCL2 expression. MC2884-treatment reduced acetylation of the BCL2 promoter at higher level than combined p300 and EZH2 inhibition. This suggests a key role for BCL-2 reduction in potentiating responsiveness, also in combination therapy with BCL2 inhibitors. Finally, we identified both the mechanism of MC2884 action as well as a potential therapeutic scheme of its use. Altogether, this provides proof of concept for the use of epi-drugs coupled with epigenome analyses to 'personalize' precision medicine.


Fichier principal
Vignette du fichier
25428-1004878-5-PB.pdf (6.32 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-01873834 , version 1 (17-09-2018)




Francesca Petraglia, Abhishek Singh, Vincenzo Carafa, Angela Nebbioso, Mariarosaria Conte, et al.. Combined HAT/EZH2 modulation leads to cancer-selective cell death. Oncotarget, 2018, 9 (39), pp.25630-25646. ⟨10.18632/oncotarget.25428⟩. ⟨hal-01873834⟩
472 View
52 Download



Gmail Mastodon Facebook X LinkedIn More